Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Lichen planopilaris can occur with multiple autoimmune diseases.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Hair transplants can cause hair loss if done while lichen planopilaris is active; wait until it's inactive for two years and check with a scalp biopsy first.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

Oral zinc and Nd:YAG laser therapy effectively treated primary cicatricial alopecia in five patients.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Lichen planopilaris can be accurately diagnosed and effectively treated.

FFA has higher long-term remission rates than LPP.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

Patients with lichen planopilaris have a higher risk of heart disease.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.